Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child.

Rod Shinozaki, Paul Krogstad, Kristina Adachi, Yonca Bulut

Abstract read

In one paragraph

Article in Case reports in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child.Case reports in pediatrics · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rod ShinozakiDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, Loma Linda University Children's Hospital, Loma Linda, California, USA.ORCID https://orcid.org/0000-0001-5535-2351

Paul KrogstadDepartment of Pediatrics, Division of Pediatric Infectious Diseases, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0001-6191-6213

Kristina AdachiDepartment of Pediatrics, Division of Pediatric Infectious Diseases, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0002-5796-2767

Yonca BulutDepartment of Pediatrics, Division of Critical Care Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0003-2340-5855

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coccidioidomycosis (CM) is an emerging public health challenge due to an increasing number of cases in the U.S. Diagnosis may be challenging because of its nonspecific presentation, which may lead to treatment delays. In addition, the optimal management of severe pulmonary CM remains unclear. We present the case of an 18-year-old immunocompromised renal transplant recipient with a history of systemic lupus erythematosus who developed acute respiratory distress syndrome (ARDS) secondary to severe pulmonary CM. Following initiation of systemic corticosteroids treatment with standard-of-care antifungals, she demonstrated improved clinical response. Severe pulmonary CM may lead to a significant multiorgan inflammatory response in this infection. Our case explores corticosteroid treatment to downregulate this pathophysiologic process and help facilitate clinical resolution of the critical respiratory symptoms and limit morbidity associated with this infection.

Indexed as

ARDScoccidioidomycosiscorticosteroidspediatricValley Fever

Identifiers

PMID42328354

DOI10.1155/crpe/6010113

PMCPMC13280571

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.